Deal Snapshot
GENERATIONAL EQUITY ADVISES LGM PHARMA IN SALE TO NEW HARBOR CAPITAL
Wednesday 06 December 2017

US-based mergers and acquisitions advisor Generational Equity advised its client, US-based API company LGM Pharma, in its majority sale to US-based private equity firm New Harbor Capital LLC the firm said. LGM specialises in streamlining the API supply chain throughout all development stages while providing complete technical capabilities and expert regulatory support for a range of products.
The company serves many active customers across biotech, generic pharma, contract manufacturing, specialty pharma, CDMOs, academic institutes, compounding and pharmaceutical manufacturing industries, supporting all stages of drug development and commercialization by supplying a wide range of APIs and by providing other value-added services.


TKUqg0 http://www.FyLitCl7Pf7kjQdDUOLQOuaxTXbj5iNG.com
Details
Date Published: 06/12/2017
Target: LGM Pharma/majority stake
Country: USA
Sector: Pharmaceuticals
Type: LBO
Financing:
Status: Closed
Vendor:
Buyer: New Harbor Capital
Comment:
Terms of the deal were not disclosed

Options